Medicare Enrolled
Dr. Parinda Fruchtman, MD
Family Medicine · Salisbury, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fruchtman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fruchtman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fruchtman
Dr. Parinda Fruchtman is a family medicine specialist in Salisbury, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Fruchtman performed 1,144 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Fruchtman received a total of $16,697 from 74 pharmaceutical and/or device companies across 959 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fruchtman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 25% volume in NC
$16,697 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,144
Medicare services
Top 25% in NC for family medicine
Not available
Unique patients (not deduplicated)
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
728 | $87 | $229 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
132 | $8 | $10 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
93 | $10 | $25 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
82 | $1 | $8 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
26 | $48 | $100 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
24 | $12 | $30 |
| Substance misuse assessment and brief intervention A structured assessment of alcohol or substance misuse combined with a brief intervention lasting 15 to 30 minutes. |
23 | $26 | $50 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
18 | $32 | $45 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
18 | $29 | $35 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$16,697
Total received (2018-2024)
Avg $2,385/year across 7 years
Top 2% in NC for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
74
Companies
959
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,929
2023
$2,696
2022
$2,566
2021
$3,358
2020
$2,135
2019
$1,450
2018
$2,563
Payments by company (2024)
ABBVIE INC.
$526
Astellas Pharma US Inc
$336
Collegium Pharmaceutical, Inc.
$218
Forte Bio-Pharma LLC
$198
GlaxoSmithKline, LLC.
$98
PFIZER INC.
$95
AstraZeneca Pharmaceuticals LP
$60
Ardelyx, Inc.
$55
Lilly USA, LLC
$55
Paratek Pharmaceuticals, Inc.
$43
SCILEX PHARMACEUTICALS INC.
$39
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$38
Dexcom, Inc.
$24
Corcept Therapeutics
$23
Mylan Specialty L.P.
$22
IDORSIA PHARMACEUTICALS US INC
$20
IRONWOOD PHARMACEUTICALS, INC
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Amgen Inc.
$16
SHIELD THERAPEUTICS INC
$16
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$14
Top 3 companies account for 56.0% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,739
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,317
Astellas Pharma US Inc
$1,182
Collegium Pharmaceutical, Inc.
$1,049
PFIZER INC.
$1,015
AstraZeneca Pharmaceuticals LP
$1,001
Amgen Inc.
$949
Vanda Pharmaceuticals Inc.
$741
Janssen Pharmaceuticals, Inc
$639
Forte Bio-Pharma LLC
$602
Lilly USA, LLC
$491
Allergan Inc.
$483
AbbVie Inc.
$423
Daiichi Sankyo Inc.
$323
GlaxoSmithKline, LLC.
$309
Allergan, Inc.
$301
Novo Nordisk Inc
$301
SCILEX PHARMACEUTICALS INC.
$284
Mylan Specialty L.P.
$261
Takeda Pharmaceuticals U.S.A., Inc.
$208
Pernix Therapeutics Holdings, Inc.
$198
Boehringer Ingelheim Pharmaceuticals, Inc.
$184
Synergy Pharmaceuticals Inc
$168
SANOFI-AVENTIS U.S. LLC
$156
Ironwood Pharmaceuticals, Inc
$141
Sunovion Pharmaceuticals Inc.
$127
Biohaven Pharmaceutical Holding Company Ltd.
$127
Scilex Pharmaceuticals Inc.
$121
Paratek Pharmaceuticals, Inc.
$117
Novartis Pharmaceuticals Corporation
$108
Boston Scientific Corporation
$106
Eisai Inc.
$103
Exact Sciences Corporation
$101
Dexcom, Inc.
$75
Supernus Pharmaceuticals, Inc.
$73
GRT US Holding, Inc.
$66
Corcept Therapeutics
$58
Otsuka America Pharmaceutical, Inc.
$57
Ardelyx, Inc.
$55
Virtus Pharmaceuticals LLC
$54
Bayer Healthcare Pharmaceuticals Inc.
$54
BioDelivery Sciences International, Inc.
$49
IDORSIA PHARMACEUTICALS US INC
$41
Teva Pharmaceuticals USA, Inc.
$41
Sentynl Therapeutics, Inc.
$39
Xeris Pharmaceuticals, Inc.
$37
FORTE BIO-PHARMA LLC
$36
IMPEL PHARMACEUTICALS INC.
$36
IRONWOOD PHARMACEUTICALS, INC
$36
IBSA Pharma Inc.
$35
Purdue Pharma L.P.
$33
Biohaven Pharmaceuticals, Inc.
$31
Avanir Pharmaceuticals, Inc.
$30
Kowa Pharmaceuticals America, Inc.
$29
Amarin Pharma Inc.
$27
ARBOR PHARMACEUTICALS, INC.
$24
DEXCOM, INC.
$23
RedHill Biopharma Inc.
$23
Avanos Medical
$23
INSYS Therapeutics Inc
$20
Abbott Laboratories
$19
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$18
Merck Sharp & Dohme Corporation
$18
Neurocrine Biosciences, Inc.
$17
ITI, Inc.
$17
Almatica Pharma LLC
$17
Bayer HealthCare Pharmaceuticals Inc.
$17
Shire North American Group Inc
$16
SHIELD THERAPEUTICS INC
$16
E.R. Squibb & Sons, L.L.C.
$15
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$14
Ironshore Pharmaceuticals Inc.
$13
Promius Pharma LLC
$12
SANOFI PASTEUR INC.
$12
Top 3 companies account for 25.4% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIMOVIG · AIRSUPRA · AJOVY · APTIOM · AREXVY · Aimovig · Amitiza · BELBUCA · BELSOMRA · BOTOX · BREO · BREZTRI · BREZTRI AEROSPHERE · BUNAVAIL 2.1 mg 30-count box · BYSTOLIC · Belbuca · CAPLYTA · CHANTIX · COLOGUARD · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · DUZALLO · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMBEDA · EMGALITY · ENTRESTO · FANAPT · FARXIGA · FLECTOR · Fanapt · GEMTESA · GRALISE · GVOKE PFS · HETLIOZ · Horizant · IBSRELA · INGREZZA · INJECTAFER · INVEGA SUSTENNA · INVOKANA · JARDIANCE · Jornay 100 mg capsules (Bottle of 100) · Kerendia · Korlym · LACTULOSE · LEQVIO · LEVORPHANOL TARTRATE · LINZESS · LONHALA MAGNAIR · LYRICA · Levorphanol · Licart · Linzess · MOUNJARO · MYDAYIS · MYRBETRIQ · Morphabond ER · Motegrity · Movantik · Myrbetriq · NALOCET · NUEDEXTA · NURTEC ODT · NUZYRA · Nalocet · Nucynta ER · OXTELLAR XR · Otezla · Ozempic · PRALUENT · PREMARIN · PROCLAIM · PROLATE · Prolia · QULIPTA · QUVIVIQ · Qutenza · RELISTOR · REXULTI · REYVOW · RYBELSUS · Repatha · Rybelsus · SOLIQUA 100/33 · STIOLTO RESPIMAT · SUBSYS · SYMBICORT · SYMPROIC · Seglentis · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRIVISC SODIUM HYALURONATE · TROKENDI XR · TRULANCE · TRULICITY · Tresiba · Trintellix · Trudhesa · Trulance · UBRELVY · VAXELIS · VIBERZI · VIIBRYD · VRAYLAR · VYVANSE · Vascepa · Veozah · XARELTO · XIFAXAN · XTAMPZA · Xtampza ER · YUPELRI · Yupelri · ZENPEP · ZOHYDRO ER · ZTLido · Zembrace
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family medicine physicians in nearby ZIP areas
284
County median income
$63,196
Nearest hospital to ZIP centroid (approximate)
NOVANT HEALTH ROWAN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fruchtman is a clinical cardiology specialist, with above-average Medicare volume (top 25% in NC), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fruchtman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Fruchtman performed 728 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Fruchtman receive payments from pharmaceutical companies?
Yes. Dr. Fruchtman received a total of $16,697 from 74 companies across 959 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fruchtman's costs compare to other family medicine physicians in Salisbury?
Dr. Fruchtman's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fruchtman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Salisbury
Browse family medicine physicians in Salisbury ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in NC
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in NC
Which NC family medicine physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology